Production and characterisation of the first human monoclonal antibodies against Plasmodium falciparum transmission blocking antigen Pfs25

Production and characterisation of the first human monoclonal antibodies against Plasmodium falciparum transmission blocking antigen Pfs25

Bibliographic Details
Main Authors:	Zaric, M, Ellis, K, Ellias, S, Marini, A, Miura, K, Long, C, Donnellan, F, Nielsen, C, Draper, S, Biswas, S
Format:	Conference item
Language:	English
Published:	Wiley 2019

Similar Items

Induction of Plasmodium falciparum transmission-blocking antibodies by recombinant Pfs25
by: David C. Kaslow, et al.
Published: (1992-01-01)

New adenovirus-based vaccine vectors targeting Pfs25 elicit antibodies that inhibit Plasmodium falciparum transmission
by: Kathleen A. McGuire, et al.
Published: (2017-06-01)

Poor CD4+ T Cell Immunogenicity Limits Humoral Immunity to P. falciparum Transmission-Blocking Candidate Pfs25 in Humans
by: Marija Zaric, et al.
Published: (2021-09-01)

Pfs230 and Pfs48/45 Fusion Proteins Elicit Strong Transmission-Blocking Antibody Responses Against Plasmodium falciparum
by: Susheel K. Singh, et al.
Published: (2019-06-01)

Generation and characterisation of monoclonal antibodies specific to Plasmodium falciparum enolase
by: Ipsita Pal-Bhowmick, Hardeep K. Vora, Jaya Roy, Shobhona Sharma , Gotam K. Jarori
Published: (2006-06-01)

mRNA-LNP expressing PfCSP and Pfs25 vaccine candidates targeting infection and transmission of Plasmodium falciparum
by: Clifford T. H. Hayashi, et al.
Published: (2022-12-01)

Antibodies to plant-produced Plasmodium falciparum sexual stage protein Pfs25 exhibit transmission blocking activity.
by: Farrance, C, et al.
Published: (2011)

Antibodies to plant-produced Plasmodium falciparum sexual stage protein Pfs25 exhibit transmission blocking activity
by: Farrance, C, et al.
Published: (2011)

Particle-based, Pfs230 and Pfs25 immunization is effective, but not improved by duplexing at fixed total antigen dose
by: Wei-Chiao Huang, et al.
Published: (2020-08-01)

Structural analysis of Plasmodium falciparum ookinete surface antigen Pfs28 relevant for malaria vaccine design
by: Niharika Shukla, et al.
Published: (2022-11-01)

The dynamics of naturally acquired immune responses to Plasmodium falciparum sexual stage antigens Pfs230 & Pfs48/45 in a low endemic area in Tanzania.
by: Teun Bousema, et al.
Published: (2010-11-01)

Attempts to define Plasmodium Falciparum antigens with human monoclonal antibodies
by: C. Desgrandes, et al.
Published: (1986-01-01)

Global diversity of the gene encoding the Pfs25 protein—a Plasmodium falciparum transmission-blocking vaccine candidate
by: Pornpawee Sookpongthai, et al.
Published: (2021-11-01)

Development and Qualification of an Antigen Integrity Assay for a <i>Plasmodium falciparum</i> Malaria Transmission Blocking Vaccine Candidate, Pfs230
by: Kazutoyo Miura, et al.
Published: (2022-09-01)

Author Correction: mRNA-LNP expressing PfCSP and Pfs25 vaccine candidates targeting infection and transmission of Plasmodium falciparum
by: Clifford T. H. Hayashi, et al.
Published: (2023-08-01)

Gametocyte carriage of Plasmodium falciparum (pfs25) and Plasmodium vivax (pvs25) during mass screening and treatment in West Timor, Indonesia: a longitudinal prospective study
by: Kosasih, A, et al.
Published: (2021)

Structural and immunological differences in Plasmodium falciparum sexual stage transmission-blocking vaccines comprised of Pfs25-EPA nanoparticles
by: Nicholas J. MacDonald, et al.
Published: (2023-04-01)

A human antibody epitope map of the malaria vaccine antigen Pfs25
by: Niharika Shukla, et al.
Published: (2023-08-01)

A viral vectored prime-boost immunization regime targeting the malaria Pfs25 antigen induces transmission-blocking activity.
by: Goodman, A, et al.
Published: (2011)

Risk factors for patent and sub-patent gametocyte carriage of Plasmodium falciparum (pfs25) and Plasmodium vivax (pvs25) in hypo- to meso-endemic West Timor in Eastern Indonesia
by: Kosasih, AA, et al.
Published: (2019)

Vaccine co-display of CSP and Pfs230 on liposomes targeting two Plasmodium falciparum differentiation stages
by: Wei-Chiao Huang, et al.
Published: (2022-08-01)

Adeno-associated viral vectored delivery of a novel monoclonal antibody gene against blood-stage Plasmodium falciparum malaria
by: Bardelli, M, et al.
Published: (2018)

A viral vectored prime-boost immunization regime targeting the malaria Pfs25 antigen induces transmission-blocking activity.
by: Anna L Goodman, et al.
Published: (2011-01-01)

Combination of RTS,S and Pfs25-IMX313 induces a functional antibody response against malaria infection and transmission in mice
by: Brod, F, et al.
Published: (2018)

Enhancing immunogenicity and transmission-blocking activity of malaria vaccines by fusing Pfs25 to IMX313 multimerization technology.
by: Li, Y, et al.
Published: (2016)

Safety and Immunogenicity of Pfs25-EPA/Alhydrogel®, a Transmission Blocking Vaccine against Plasmodium falciparum: An Open Label Study in Malaria Naïve Adults.
by: Kawsar R Talaat, et al.
Published: (2016-01-01)

A plant-produced Pfs25 VLP malaria vaccine candidate induces persistent transmission blocking antibodies against Plasmodium falciparum in immunized mice.
by: R Mark Jones, et al.
Published: (2013-01-01)

A Reproducible and Scalable Process for Manufacturing a Pfs48/45 Based Plasmodium falciparum Transmission-Blocking Vaccine
by: Susheel K. Singh, et al.
Published: (2021-01-01)

Molecular definition of multiple sites of antibody inhibition of malaria transmission-blocking vaccine antigen Pfs25
by: Stephen W. Scally, et al.
Published: (2017-11-01)

mRNA vaccines expressing malaria transmission-blocking antigens Pfs25 and Pfs230D1 induce a functional immune response
by: Puthupparampil V. Scaria, et al.
Published: (2024-01-01)

Safety and immunogenicity of ChAd63/MVA Pfs25-IMX313 in a Phase I first-in-human trial
by: de Graaf, H, et al.
Published: (2021)

Identification and characterisation of candidate monoclonal antibody Ebolavirus therapeutics
by: Donnellan, FR
Published: (2021)

Complement activation by merozoite antigens of Plasmodium falciparum.
by: Jackson C Korir, et al.
Published: (2014-01-01)

Combination of RTS,S and Pfs25-IMX313 Induces a Functional Antibody Response Against Malaria Infection and Transmission in Mice
by: Florian Brod, et al.
Published: (2018-12-01)

Antigenic variation in Plasmodium falciparum: mechanisms and consequences.
by: Newbold, C
Published: (1999)

Expanding the malaria antibody toolkit: development and characterisation of Plasmodium falciparum RH5, CyRPA, and CSP recombinant human monoclonal antibodies
by: Nacer, A, et al.
Published: (2022)

Safety and Immunogenicity of ChAd63/MVA Pfs25-IMX313 in a Phase I First-in-Human Trial
by: Hans de Graaf, et al.
Published: (2021-07-01)

Expanding the Malaria Antibody Toolkit: Development and Characterisation of Plasmodium falciparum RH5, CyRPA, and CSP Recombinant Human Monoclonal Antibodies
by: Adéla Nacer, et al.
Published: (2022-06-01)

Monoclonal Antibodies against Plasmodium falciparum Circumsporozoite Protein
by: Min Zhang, et al.
Published: (2017-08-01)

Antigens of the asexual stages of plasmodium falciparum
by: G. V. Brown, et al.
Published: (1986-01-01)